Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cytomegalovirus and male infertility.
Torino G, Bizzarro A, Castello G, Daponte A, Fontana A, De Bellis A, Paglionico VA. Torino G, et al. Among authors: castello g. Ann Biol Clin (Paris). 1987;45(4):440-3. Ann Biol Clin (Paris). 1987. PMID: 2823646
T-lymphocyte-subsets in endocrine exophthalmos.
Cenmamo G, Bizzarro A, Castello G. Cenmamo G, et al. Among authors: castello g. Metab Pediatr Syst Ophthalmol (1985). 1985;8(2-3):43-5. Metab Pediatr Syst Ophthalmol (1985). 1985. PMID: 3879963
[TAC-positive lymphocytes in Basedow's disease].
Bizzarro A, Fontana A, De Bellis A, Daponte A, Gentile S, Castello G, Iacono G. Bizzarro A, et al. Among authors: castello g. Ann Ital Med Int. 1987 Apr-Jun;2(2):118-24. Ann Ital Med Int. 1987. PMID: 3275278 Italian. No abstract available.
Simultaneous evaluation of the circulating levels of both Th1 and Th2 chemokines in patients with autoimmune Addison's disease.
Bellastella G, Rotondi M, Pane E, Costantini S, Colella C, Calemma R, Capone F, Falorni A, Castello G, Sinisi AA, Bizzarro A, Chiovato L, Bellastella A, De Bellis A. Bellastella G, et al. Among authors: castello g. J Endocrinol Invest. 2011 Dec;34(11):831-4. doi: 10.3275/7414. Epub 2010 Dec 15. J Endocrinol Invest. 2011. PMID: 21169727
Intermediate dose recombinant interferon-alpha as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferon.
Ascierto PA, Daponte A, Parasole R, Perrone F, Caracò C, Melucci M, Palmieri G, Napolitano M, Mozzillo N, Castello G. Ascierto PA, et al. Among authors: castello g. Cancer. 2000 Oct 1;89(7):1490-4. doi: 10.1002/1097-0142(20001001)89:7<1490::aid-cncr11>3.0.co;2-v. Cancer. 2000. PMID: 11013362 Clinical Trial.
221 results